Altered Sleep Homeostasis in Rev-erbα Knockout Mice. by Mang, G.M. et al.
   
 
 
 
 
Serveur Acade´mique Lausannois SERVAL serval.unil.ch
Author Manuscript
Faculty of Biology and Medicine Publication
This paper has been peer-reviewed but does not include the final publisher
proof-corrections or journal pagination.
Published in final edited form as:
Title: Altered Sleep Homeostasis in Rev-erbα Knockout Mice.
Authors: Mang GM, La Spada F, Emmenegger Y, Chappuis S, Ripperger
JA, Albrecht U, Franken P
Journal: Sleep
Year: 2016 Mar 1
Issue: 39
Volume: 3
Pages: 589-601
DOI: 10.5665/sleep.5534
In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains
an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article.
Altered sleep homeostasis in Rev-erbα knockout mice 
 
Géraldine M. Mang1 Ph.D., Francesco La Spada1 Ph.D., Yann Emmenegger1, Sylvie Chappuis2 
Ph.D., Jürgen A. Ripperger2 Ph.D., Urs Albrecht2§ Ph.D., and Paul Franken1§ Ph.D. 
 
 
1 Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland 
2 Faculty of Science, Department of Biology, Biochemistry, University of Fribourg, Fribourg, 
Switzerland 
 
 
 
 
 
 
   
 
 
 
§Share last authorship 
 
Corresponding author: 
Paul Franken 
Center for Integrative Genomics 
University of Lausanne 
1015 Lausanne, Switzerland 
e-mail:  paul.franken@unil.ch 
phone/fax: +41 21 6923972 / -65 
 
Disclosure  
This study was performed at the Universities of Lausanne and Fribourg, Switzerland, and supported by 
the Swiss National Science Foundation (SNF n°130825 and 136201 to PF and SNF n°146265 to UA) and 
the states of Vaud supporting GMM, YE, and PF and Fribourg supporting JAR and UA. 
 
Conflict of Interest 
No conflict of interest has to be declared. 
 
Subtitle 
Loss of Rev-erbα alters sleep homeostasis 
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Abstract 
Study objectives: The nuclear receptor REV-ERBα is a potent, constitutive transcriptional 
repressor critical for the regulation of key circadian and metabolic genes. Recently, REV-
ERBα’s involvement in learning, neurogenesis, mood, and dopamine turnover was 
demonstrated suggesting a specific role in central nervous system functioning. We have 
previously shown that the brain expression of several core clock genes, including Rev-erbα, is 
modulated by sleep loss. We here test the consequences of a loss of REV-ERBα on the 
homeostatic regulation of sleep. 
Design: Sleep recordings during baseline, sleep deprivation, and recovery. Gene expression 
measurements after sleep deprivation. 
Setting: Mouse sleep laboratory. 
Participants: Male Rev-erbα knockout (KO) mice and their wild type (WT) littermates.  
Intervention: Sleep deprivation. 
Measurements and Results: Although baseline sleep/wake duration was remarkably similar, 
KO mice showed an advance of the sleep/wake distribution relative to the light-dark cycle. 
After sleep onset in baseline and after sleep deprivation, both EEG delta power (1-4Hz) and 
sleep consolidation were reduced in KO mice indicating a slower increase of homeostatic sleep 
need during wakefulness. This slower increase might relate to the smaller increase in theta 
and gamma power observed in the waking EEG prior to sleep onset under both conditions. 
Indeed, the increased theta activity during wakefulness predicted delta power in subsequent 
NREM sleep. Lack of Rev-erbα increased Bmal1, Npas2, Clock, and Fabp7 expression, 
confirming the direct regulation of these genes by REV-ERBα also in the brain. 
Conclusion: Our results add further proof to the notion that clock genes are involved in sleep 
homeostasis. Because accumulating evidence directly links REV-ERBα to dopamine signaling 
the altered homeostatic regulation of sleep reported here are discussed in that context. 
 
 
Keywords: Clock genes, mood, depression, neurogenesis, Process S, slow wave activity. 
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Introduction 
The timing and quality of sleep are controlled by the interaction of a homeostatic process, that 
tracks sleep need as a function of the previous sleep/wake history, and a circadian process 
that ensures the appropriate timing of sleep relative to the daily light-dark alternation 1,2. 
Although these two processes seem functionally and neuro-physiologically distinct, at the 
molecular level, several core components of the circadian timing system were found to also 
play a role in maintaining proper sleep homeostasis (for review see 3,4). 
The molecular circadian oscillator consists of positive and negative elements. In 
mammals the positive elements comprise of CLOCK, NPAS2, and BMAL1, with 
CLOCK/NPAS2:BMAL1 heterodimers driving the transcription of many target genes including 
that of the Period (Per1, -2) and Cryptochrome (Cry1, -2) genes (reviewed in 5). PER:CRY protein 
complexes suppress CLOCK/NPAS2:BMAL1-mediated transcription, including their own, 
thereby constituting the negative elements in this core feedback loop. Additional interactions 
between these core clock genes at the level of transcription, translocation back into the 
nucleus, and post-translational modifications add further complexity and stability to the 
circuit. One important auxiliary feedback loop involves the orphan nuclear receptor REV-
ERBα, which binds to specific sequences in the promoters of all three positive elements 6,7 and 
inhibits their transcription 8-11. In turn, Rev-erbα expression is directly regulated by 
CLOCK/NPAS2:BMAL1-mediated transcription 8,12. Given REV-ERBα’s ability to reset the phase 
of the molecular clock oscillation and to entrain central and peripheral clocks, it has been 
suggested to function as a synchronizing ‘hinge’ of the clock gene machinery 13 enabling it to 
act as ‘gatekeeper’ in coordinating the circadian metabolic response 14. 
The REV-ERBα protein, encoded by the Nr1d1 (nuclear receptor subfamily 1, group D, 
member 1) gene, regulates gene transcription through binding to specific DNA sequences 
comprising an A/T-rich flank followed by AGGTCA in the promoter region of target genes 15,16. 
REV-ERBα is part of the ligand-binding receptor family, but lacks the carboxy-terminal tail of 
the ligand-binding domain required for co-activation and thus necessary for transcriptional 
activation 17. As a consequence, upon activation by its ligand, heme, REV-ERBα is a constitutive 
repressor of gene expression 16,18-21 . 
Beside its important role in the generation of circadian rhythms, REV-ERBα is 
implicated in the regulation of various metabolic pathways including adipocyte 
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differentiation, gluconeogenesis, bile acid synthesis, and heme and cholesterol homeostasis 
20,22-24. Consistent with its function, Rev-erbα is highly expressed in metabolic tissues with high 
rates of metabolism such as adipose tissue, liver, skeletal muscle, and brain 25,26. Rev-erbα 
deletion impacts the expression of many metabolic genes, in particular genes involved in lipid 
metabolic pathways 12. The administration of REV-ERBα agonists in mice decreased diet-
induced obesity by reducing fat content and improving hyperglycemia and dyslipidaemia 27. 
The expression of Rev-erbα can be directly activated through the peroxisome proliferator-
activated receptors (PPARs) that play essential roles in energy metabolism and are themselves 
expressed in a circadian manner (for review see 28). REV-ERBα is a heme sensor and crucial for 
heme homeostasis thereby further tightening the link between metabolic and circadian 
physiology 16,19-21. 
In the context of sleep homeostasis, we have previously shown that the expression of 
Rev-erbα in the forebrain of mice is decreased after sleep deprivation29. We hypothesize that 
Rev-erbα could act as an integrator of both energy demand and sleep pressure. With the aim 
to establish such role, we evaluated sleep, the EEG, and cortical gene expression under 
baseline and sleep deprivation conditions, in Rev-erbα knockout (KO) mice and their wild-type 
(WT) littermate controls. 
 
Material & methods 
Animals and housing conditions 
Rev-erbα KO mice were kindly provided by Ueli Schibler (University of Geneva, Geneva, 
Switzerland) and maintained on a mixed 129/Sv x C57BL6 background. In these mice, exons 3 
and 4, encoding the DNA binding domain, and part of exons 2 and 5 of the Rev-erbα gene, 
were replaced by an in-frame lacZ allele and a PGK-neo gene by homologous recombination 
in 129/SV ES cells, resulting in the absence of the transcript and protein 8. Wild type (WT) 
littermates were used as control animals. Mice were individually housed in polycarbonate 
cages (31×18×18 cm) in a temperature and humidity controlled room (25°C, 50-60% 
respectively) and a 12h light/12h dark cycle (lights on at 9 am, 70-90 lux). Animals had access 
to food and water ad libitum. All experiments were approved by the Ethical Committee of the 
State of Vaud Veterinary Office, Switzerland. 
 
4 
 
EEG/EMG implantation 
At the age of 9 to 14 weeks, 13 KO and 9 WT male mice were implanted with EEG and EMG 
electrodes under deep Xylazine/Ketamine anesthesia as previously described 30. Briefly, six 
gold-plated screws (diameter 1.1 mm) were screwed bilaterally into the skull, over the frontal 
and parietal cortices. Two served as EEG electrodes and the remaining four anchored the 
electrode connector assembly. As EMG electrodes two gold wires were inserted into the neck 
musculature. The EEG and EMG electrodes were soldered to a connector and cemented to the 
skull. Animals were allowed to recover from surgery during 5 - 7 days before they were 
connected to the recording cables in their home cage. A minimum of 6 days were allowed for 
habituation to the cable and the experimental room prior to the experiments. Mice were 11 - 
16 weeks old at the time of experiment and age did not differ between genotypes (t-test, p = 
0.33). 
 
Experimental Protocols and Data acquisition 
EEG and EMG signals were recorded continuously for 72 h. The recording started at light onset; 
i.e., Zeitgeber Time (ZT) 0 or ZT0. During the first 48 h, mice were left undisturbed and these 
two days were considered as baseline. Starting at ZT0 of day 3, animals were sleep deprived 
by gentle handling as described previously 31 during 6 hours (ZT0 – 6). The remaining 18 h of 
day 3 were considered as recovery. 
The analog EEG and EMG signals were amplified (2000 x) and filtered and then digitized 
at 2 kHz and subsequently down sampled to 200 Hz and stored. The EEG was subjected to a 
discrete Fourier transformation yielding power spectra (range: 0 – 100 Hz; frequency 
resolution: 0.25 Hz; time resolution: consecutive 4-sec epochs; window function: Hamming). 
Hardware (EMBLA) and software (Somnologica-3) were purchased from Medcare Flaga 
(EMBLA, Thornton, USA). 
 
Determination of behavioral states 
Offline, the animal’s behavior was visually classified as “Wakefulness”, “REM sleep”, or “NREM 
sleep” for consecutive 4-sec windows based on the EEG and EMG signals as previously 
described 30. Wakefulness was characterized by EEG activity of mixed frequency and low 
amplitude. Muscle tone was present and variable. NREM sleep was defined by synchronous 
activity in the delta frequency (1 - 4 Hz) and low and stable muscle tone. REM sleep was 
5 
 
characterized by regular theta oscillations (6 - 9 Hz) and muscle atonia with occasional 
twitches. Four-sec epochs containing EEG artifacts were marked according to the state in 
which they occurred and excluded from EEG spectral analysis. As the sleep/wake state of 
epochs in which EEG artifacts occurred could still be determined, they were included in the 
analysis of time-spent-asleep and -awake. 
 
Data analysis 
Analysis of the time course of time spent in each sleep/wake state was performed on 1-, 12-, 
and 24h values. For the 12h and 24h analysis, the two baseline days were averaged, as no 
significant differences between the two days were observed [(3-way repeated measures 
analysis of the variance (rANOVA)3-way rANOVA, factors ‘day’, ‘time’, and ‘genotype’; p > 0.14 
for factor ‘day’ and all its interactions]). To further quantify the altered baseline distribution 
of sleep/wake states in KO mice, hourly values were accumulated over baseline and genotype 
differences calculated to assess the times at which the two distributions deviated. 
Sleep/wake state quality was assessed by analyzing the spectral content of the EEG. To 
account for inter-individual differences in overall EEG power, EEG spectra of the three 
sleep/wake states were expressed as a percentage of an individual reference value calculated 
as the total EEG power across all frequencies considered (0.75 – 45.0 Hz) and sleep/wake 
states. This reference value was weighted so that for all animals the relative contribution of 
the three sleep/wake states to this reference value was equal, according to 32. Theta peak 
frequency in wakefulness and REM sleep was calculated by determining the frequency at 
which maximum power density in the theta frequency range (5 – 10 Hz) was reached. 
Effects of sleep deprivation were assessed by analyzing EEG delta power, sleep 
fragmentation, and time spent asleep. Time course analysis of EEG delta power (i.e., the mean 
EEG power density in the 1 - 4 Hz range in NREM sleep) during baseline and after sleep 
deprivation was performed as described previously 33. Briefly, the recording was divided into 
sections to which an equal number of 4-sec epochs scored as NREM sleep contributed (i.e., 
percentiles). The baseline light periods were divided into twelve such sections; the baseline 
and recovery dark periods into six. The recovery light (ZT6-12) period was divided into eight 
sections. The number ofse percentiles per recording period wasere chosen to assure that 
sufficient and similar numbers of NREM sleep epochs contributed to each interval necessary 
to obtain meaningful mean delta power values. Delta power values were normalized by 
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expressing all values relative to the mean value reached in the last 4 h of the main rest periods 
(i.e., ZT8 - 12) when delta power is minimal during baseline consistent with the fact that delta 
power is thought to reflect homeostatic sleep need which is lowest at the end of the major 
rest period. Besides its time course, delta power levels reached immediately after sleep onset 
in baseline and after sleep deprivation were determined separately. To assure that the same 
number of 4-sec epochs contributed, delta power was averaged over the first 20 min (300 4-
sec epochs) scored as NREM sleep. Sleep onset was determined as the entry into the first 
episode of NREM sleep lasting > 1 min and not interrupted by two or more 4-sec epochs of 
wakefulness. This first episode was determined from light onset in the baseline days and from 
the end of the sleep deprivation for the recovery period. 
The effect of 6h sleep deprivation on time spent in and NREM and REM sleep was 
assessed by calculating the recovery-baseline difference in sleep time for 6h intervals; i.e., the 
first 6 h of recovery still in the light period (ZT6 - 12) and two 6h intervals in the dark (ZT12 - 
18 and ZT18 - 24). The effect of sleep deprivation on NREM sleep spectra and sleep 
fragmentation was assessed by contrasting EEG spectra and the number of short awakenings 
(waking bouts lasting 4 consecutive 4s-epochs or less; i.e., <16 s, expressed per hour of NREM 
sleep;31) during the first 3 hours of recovery sleep after sleep onset (ZT6 - 9) from the values 
observed during the last 4 hours of the baseline light periods (ZT8 - 12), a period during which 
homeostatic sleep need (and EEG delta power) is lowest and sleep fragmentation highest. 
Similarly, NREM sleep spectra and the number of brief awakenings in the first 3 hours after 
sleep onset (ZT0 - 3) in the two baseline days was calculated and contrasted to the same 
reference.  
 
Cortical gene expression analysis 
Nine KO and 10 WT male mice were used to assess the effect of genotype and sleep 
deprivation on cortical gene expression. In each genotype, half the mice were submitted to a 
6h sleep deprivation (ZT0 – 6), and the other half was left undisturbed and used as control. At 
ZT6, both groups of mice were sacrificed, the cerebral cortex extracted, and immediately flash 
frozen in liquid nitrogen. Samples were stored at -80°C. RNA was extracted and purified using 
the RNeasy Lipid Tissue Mini Kit 50 (QIAGEN, Hombrechtikon, Switzerland) according to 
manufacturer’s instructions. RNA quantity (NanoDrop ND-1000 spectrophotometer; Thermo 
Scientific, Wilmington, NC, USA) and quality (Agilent 2100 bioanalyzer chips; Agilent 
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technologies, Basel, Switzerland) was measured and verified. 1000 ng of purified RNA were 
reverse-transcribed in 20 μl using random hexamers and Superscript II reverse transcriptase 
(Invitrogen, Life Technologies, Europe, Zug, Switzerland) according to standard procedures. 
The cDNA was diluted 10 times and 2 μl were amplified in a 10 μl TaqMan reaction in technical 
triplicates on a ABI PRISM HT 7900 detection system (Applied Biosystems, Life Technologies, 
Europe, Zug, Switzerland). Cycler conditions were 50°C 2 min, 95°C 10 min, and 45 cycles at 
95°C 15 s and 60°C 1 min. To quantify the RNA expression level, specific forward and reverse 
primers and probes were used (Table S2). Gene expression levels were normalized to 4 
reference genes (Gapdh, Tbp, Rsp9, and Eef1a1) using QbasePLUS software (Biogazelle, 
Zwijnaarde, Belgium) except for Fabp7 which was expressed relative to Gapdh only. The fold 
change indicative of the relative gene expression are based on the mean of three biological 
replicates in relation to control samples. 
 
Statistics and analysis tools 
TMT Pascal Multi-Target5 software (Framework Computers, Inc., Brighton, MA, USA) was used 
to manage the data, SigmaPlot V10.0 (Systat Software Inc., Chicago, IL, USA) for graphics, and 
SAS V9.2 (SAS Institute Software Inc., Cary, NC, USA) or Sigmastat V3.5. (Systat Software, 
Chicago, IL, USA) for statistical analysis. To assess the effect of genotype on the sleep/wake 
distribution, EEG power spectra, and time course of delta power, two- or three-way repeated 
measures analysis of the variance (rANOVAs)  were performed. Significant effects and 
interactions were decomposed using post-hoc Tukey’s HSD and t-tests. Genotype differences 
in the light/dark amount, accumulation, fragmentation of sleep/wake states, and in EEG delta 
power at sleep onset, as well as the cortical gene expression were evaluated using t-tests. 
Statistical significance was set to p = 0.05 and results are reported as mean ± standard error 
of the mean (SEM) or of the difference (SED). 
 
Results 
The sleep/wake distribution is advanced in Rev-erbα knockout mice 
Similar to WT mice, Rev-erbα KO mice were mostly asleep during the light period and mostly 
awake during the dark period (almost 2/3 of the time in the respective 12h periods; Figure 1, 
Table S1). Nevertheless, the distribution of the three sleep/wake states over the 24h day 
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importantly differed between the two genotypes (Figure 1). Differences were observed mainly 
at the time encompassing the light-to-dark transition when KO mice spent more time awake 
than their WT littermates; i.e., in the 2 h prior and 3 h following this transition (ZT10 - 15; 
Figure 1A). The dynamics of the accumulation of time spent awake over the baseline days 
summarizes this effect and demonstrates that by ZT15 KO mice accrued ca. 1 h extra 
wakefulness compared to WT mice (Figure 1B). Interestingly, this gain in wakefulness was 
rapidly lost over the subsequent 3 h (ZT15 - 18) resulting in almost identical 24h values for 
wakefulness (Figure 1B, Table S1). Similar, albeit opposite results were observed for NREM 
and REM sleep (analyses not shown). 
Because of this redistribution, KO mice spent significantly more time awake in the 12h 
light period compared to WT and more time asleep during the 12h dark period, although the 
latter effect did not reach significance levels (p = 0.07; Table S1). As a result, the differences 
between time-spent-asleep (or –awake) in the 12h dark and 12h light periods, sometimes used 
to estimate the amplitude of the diurnal sleep/wake distribution, was significantly reduced in 
KO mice for all three sleep/wake states (Table S1). To further quantify the effect of the earlier 
wake onset on this reduced diurnal amplitude, the 12h periods over which amplitude was 
calculated were systematically shifted at 1min increments (Figure 1C). Advancing the 12h 
periods by 65 ± 14 min yielded the highest diurnal amplitude in KO mice while for WT mice 
maximal amplitude was already reached with a zero shift (+3 ± 8 min; Figure 1C). This suggests 
that in KO mice the 12h dark period does not adequately cover the active period. Moreover, 
the shift with which a zero amplitude was obtained (i.e., the time of day that divides the 24h 
day into halves with equal sleep time) was advanced by 1.8 ± 0.3 h relative to WT mice (Figure 
1C). Nevertheless, the maximum dark-light amplitude was still significantly lower in KO mice 
(Figure 1C; p = 0.01, t-test) indicating that besides an earlier onset other aspects of the 
sleep/wake distribution, such as the less pronounced main waking bout (analysis not shown), 
differed between the two genotypes. 
 
Evidence of altered sleep homeostasis in Rev-erbα knockout mice 
To assess the consequence of a lack of Rev-erbα on sleep homeostasis mice were challenged 
with a 6h sleep deprivation. We found that several aspects of the response to sleep 
deprivation were altered including time spent asleep, sleep continuity, and the levels of EEG 
delta power reached. 
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Both genotypes responded to the sleep deprivation by sleeping more than in the 
corresponding periods in baseline with state-specific recovery dynamics; i.e., whereas extra 
NREM sleep was already obtained within the first 6h of recovery (i.e., during the last 6 h of the 
light period; ZT6 - 12), recovery of REM sleep was deferred to the following dark period (Figure 
2). However, for both sleep states, Rev-erbα KO mice obtained less extra sleep in the 1st 6 h of 
the recovery dark period when WT mice accrued most of the extra time spent in NREM and 
REM sleep (ZT12 - 18; Figure 2). During this time interval, KO mice did not significantly gain 
any NREM sleep (3 ± 6 min) whereas WT mice obtained 35 ± 7 min extra NREM sleep compared 
to that expressed in corresponding baseline hours (Figure 2). KO mice also gained less extra 
REM sleep (7 ± 2 min vs. 13 ± 1 min in WT mice; Figure 2B). Despite these different recovery 
dynamics, at the end of the 18h recovery period, the deficit in sleep gained in KO mice no 
longer significantly differed from WT (NREM sleep: 41 ± 10 min and 57 ± 10 min; REM sleep: 
14 ± 3 and 20 ± 3 min, for KO and WT respectively; p = 0.24 and 0.11 for NREM and REM sleep, 
respectively, t-tests). 
The general time course of the changes in EEG delta power was similar in the two 
genotypes; i.e., delta power increased during periods when waking prevails (i.e., the dark or 
active period), was highest immediately after light onset and decreased over the remainder 
of the light (or rest) period, and sleep deprivation resulted in an increase in EEG delta power 
in subsequent NREM sleep (Figure 3A). This increase was, however, significantly smaller in KO 
mice. Likewise, EEG delta power at sleep onset in baseline was lower in KO mice compared to 
WT mice (Figure 3A, B). High relative levels of EEG delta power during NREM sleep are often 
accompanied by a lower number of brief awakenings indicating deeper and more consolidated 
sleep 34. Accordingly, sleep deprivation resulted in a pronounced reduction of the number of 
brief awakenings in both genotypes (Figure 3C) compared to the baseline reference. 
Consistent with the smaller increase in EEG delta power, the decrease in the number of brief 
awakenings interrupting sleep in the first 3 h after sleep onset in baseline and after sleep 
deprivation was smaller in KO mice (rANOVA, p < 0.01; Figure 3C). Post-hoc testing revealed, 
however, that the genotype effect in recovery sleep did not reach the 5% significance level (p 
= 0.01 and 0.06, for baseline and recovery sleep, respectively). After sleep onset in baseline, 
WT mice showed a reduced number of brief awakenings to the number observed at the end 
of the baseline light periods (ZT8 - 12), while in KO mice no difference from this baseline 
reference was observed (Figure 3C). In keeping with the analysis of EEG delta power, as 
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reference for the effects on sleep fragmentation the number of brief awakenings occurring at 
the end of the baseline light periods was used (see Methods). This reference did not differ 
between genotypes (Figure S1). 
To further investigate whether the genotype differences in EEG delta power reported 
above where specific to the delta frequency range and to homeostatic sleep need we analyzed 
the spectral composition of the NREM sleep EEG. Spectra did not differ between genotypes 
when averaged over the entire 48h baseline (Figure S2A). Similarly, in the last 4h hours of the 
baseline light periods, when sleep need is considered to be lowest, no spectral differences 
were observed (Figure 4; dashed lines labeled 5 and 6 in panels A and B). In contrast, when 
sleep need was high; i.e., at the start of the baseline light periods and after sleep deprivation, 
NREM sleep spectra in Rev-erbα KO mice did deviate from WT and the frequency bins in which 
power density differed in baseline and after sleep deprivation largely overlapped (Figure 4). 
Thus under both conditions, NREM sleep EEG power density between 2.5 and 4.75 Hz was 
significantly lower in KO mice. 
Although the largest effects of sleep deprivation on the NREM sleep EEG concern the 
delta frequencies, significant recovery-to-baseline differences can be observed over a larger 
frequency range 35,36. In the current experiment, power density in frequencies up to 20 Hz 
were increased compared to baseline (Figure 4C). In addition, we found evidence that EEG 
activity in the low gamma range (32 - 45 Hz) was decreased. Although, the shape of the 
differential spectral profiles as well as the frequency ranges that were significantly affected by 
the sleep deprivation were very similar for the two genotypes, the magnitude of these changes 
was smaller in Rev-erbα KO mice. The frequency range for which the sleep deprivation effect 
was significantly smaller was again limited to the delta frequencies (1.0 - 3.75 Hz; Figure 4C).  
 
The results concerning the genotype difference in the increase in EEG delta power suggest 
that when awake, homeostatic sleep need accumulates at a slower rate in mice lacking Rev-
erbα. Given the published relationship between; e.g., theta activity in the waking EEG and 
delta activity in subsequent NREM sleep 37,38, we also quantified the spectral composition of 
waking EEG. When analyzed over the 48h baseline, EEG activity during wakefulness showed 
higher power in the higher delta frequencies (1.5 - 5.5 Hz), frequencies between 11 and 20 Hz, 
and the low gamma range (33 - 42 Hz; Figure S2). The first two of these three frequency ranges 
were similarly affected in REM sleep (Figure S2). Moreover, the prevailing theta frequency 
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during wakefulness, but not that of REM sleep, was slower in Rev-erbα KO mice. Slower theta 
oscillations in the wakefulness EEG were also observed during the sleep deprivation (Figure 
S2B). 
We next focused on the waking EEG in the 3 h immediately preceding sleep onset in 
baseline and during the last 3 h of the sleep deprivation in an attempt to identify those 
frequency components that could have contributed to the delta power differences observed 
in subsequent NREM sleep. In the last 3 h of both the baseline dark periods (ZT21 - 24) and of 
the sleep deprivation (ZT3 - 6) the waking EEG showed clear theta activity in WT mice (Figure 
5A). The appearance of a distinct theta peak in the waking EEG resulted from the combination 
of a decrease in high delta activity (3 - 6 Hz) and an increase in theta activity (6.5 - 11 Hz; Figure 
5B). In addition, in both conditions, EEG activity in the high gamma range (40 - 90 Hz) 
significantly increased compared to that observed in the last 4h of the baseline light periods 
which served as reference (Figure 5B, Figure S4). Although also in KO mice activity in the theta 
and high gamma frequency ranges was increased both in the baseline dark period and the 
sleep deprivation, the peak in theta activity during the baseline dark was less distinct because 
high delta activity remained elevated (Figure 5A, B). Moreover, the increase in theta power 
was smaller in both baseline and sleep deprivation when mice lack Rev-erbα. Correlation 
analyses showed that this increase in theta power predicted the increase in EEG delta power 
in subsequent NREM sleep (Figure 5C). In the sleep deprivation condition also the increase in 
high gamma activity was smaller in the KO mice. 
 
The molecular consequences of lack of Rev-erbα in the cerebral cortex 
To test whether the lack of Rev-erbα also affects molecular markers of sleep need, we 
investigated the cortical expression of genes that are known to be reliably modulated by sleep 
deprivation; i.e., Homer1a, Sgk1, Dbp, and Per2 (e.g. 39). Homer1a, Sgk1, and Per2 were up-
regulated by sleep deprivation and Dbp expression down-regulated although post-hoc testing 
showed that this decrease reached significance in WT mice only (Figure 6). We previously 
found that also Npas2 expression increases after sleep deprivation29 but in the current 
experiment only in KO mice this increase was significant only in KO mice. These sleep-
deprivation induced changes in cortical gene expression did, however, not statistically differ 
between the two genotypes (Figure 6). 
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Next we assessed the expression of genes known to be directly regulated by Rev-erbα, 
to test whether Rev-erbα has a similar role on these targets in the cerebral cortex. The 
expression levels of Bmal1, Npas2, Clock, and the REV-ERBα target Fabp7 (fatty acid binding 
protein 7) 40 were all significantly up-regulated in the cortex of Rev-erbα KO mice compared 
to WT (Figure 6); that of Fabp7 more than 7-fold. The overall level of Dbp and Per2 in the KO 
was also increased, although for Per2 it did not reach significance levels (p < 0.06, t-test). These 
results confirm that Rev-erbα directly, or indirectly in the case of Dbp and Per2, controls the 
expression of clock genes also in the cortex. 
 
Discussion 
REV-ERBα impacts sleep homeostasis 
In the current study we identified a robust sleep homeostatic phenotype in mice lacking Rev-
erbα. Significantly lower values for the electrophysiological correlate of homeostatic sleep 
need, EEG delta power, were reached after periods of prolonged wakefulness in KO mice 
compared to their WT littermates. This phenotype was observed both after enforced and 
spontaneous periods of wakefulness arguing against the possible influence of other variables 
than extended wakefulness that usually accompany a sleep deprivation protocol such as; e.g., 
increased stimulation, locomotion, and stress. This genotype difference in the NREM sleep 
EEG was specific to the delta frequencies and appeared only at times when sleep need was 
high. The observed differences do therefore not represent a general EEG phenomena but 
concern only those frequencies thought to reflect homeostatic sleep need. Moreover, the less 
pronounced increase in sleep consolidation, another, non-EEG variable reflecting homeostatic 
sleep need 34, confirmed that sleep immediately after sleep onset was less ‘deep’. 
Together these findings argue for a slower accumulation of sleep need when Rev-erbα 
KO mice are awake. Correlates of the homeostatic sleep process can also be quantified in the 
waking EEG, the theta content of which is known to increase over the course of extended 
waking periods (e.g. 34,38,41). Moreover, in the rat, levels of theta activity during wakefulness 
and/or time spent exploring, during which theta activity is prominent, predict delta power in 
subsequent NREM sleep 38,42 suggesting that these two EEG activities not only gauge the same 
underlying homeostatic process but that wakefulness with higher theta activity causes delta 
power to be higher during the sleep that follows. We here confirmed this relationship in the 
mouse. Rev-erbα KO mice displayed a smaller increase in theta activity during wakefulness in 
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the 3 h preceding sleep onset that predicted the lower delta power immediately after sleep 
onset. We extended these theta findings to the 35 - 90 Hz or gamma frequencies, the activity 
in which in the hippocampal formation is closely coupled to theta oscillations in the 
hippocampal formation 43,44. In both genotypes EEG activity in the gamma band was increased 
relative to the values reached when sleep need is lowest but, like for theta activity, this 
increase was less pronounced in the KO mice although the frequencies in which significant 
differences were observed concerned the 71 - 78 Hz range only. Lack of Rev-erbα may thus 
lead to deficits in either engaging in waking behaviors rich in theta activity such as exploratory 
behavior, and/or in the recruitment of neuronal populations contributing to these oscillations. 
The significantly slower theta frequency we observed during wakefulness constitutes 
additional evidence for a role of Rev-erbα in modulating theta oscillations of hippocampal 
origin. Of interest in this context is the fact that lack of Rev-erbα leads to increased adult 
neurogenesis in the hippocampus 40, which may affect the network properties contributing to 
theta oscillations 45. 
 
REV-ERBα, sleep homeostasis, and dopamine 
Impaired hippocampal function in Rev-erbα KO mice has been demonstrated for a number of 
hippocampal-dependent behaviors 40,46. This impairment was accompanied by increased 
dopamine turnover 46,47. The slower hippocampal theta oscillations we observed in Rev-erbα 
KO mice are consistent with the theta slowing observed when dopamine tone is increased as 
observed in Dopamine transporter (Dat) KO mice 48. In Rev-erbα KO mice the increased 
dopamine turnover was due to an up-regulation of Tyrosine hydroxylase (Th), the rate-limiting 
enzyme in dopamine production46,47. Rev-erbα can directly repress Th expression in 
competition with the Nuclear receptor-related 1 protein (Nurr1), another nuclear receptor and 
key transcriptional activator of Th and other elements of the dopaminergic system 47,49. Of 
immediate interest for our current study is the observation that altered dopamine levels, 
resulting from altered Dat activity, were found to be associated with a change in the 
homeostatic sleep rebound both in flies and humans 50-52. 
Other clock genes have been implicated in the regulation of dopamine levels in the 
brain 47,53,54. Such role might be direct, like REV-ERBα‘s repression of Th expression discussed 
above and for the NPAS2:BMAL1’s transcriptional activation circadian control of the dopamine 
degrading enzyme monoamine oxidase A (Maoa)54, or indirect through the effects of other 
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clock genes on the expression of e.g., Rev-erbα. For instance, CLOCK/NPAS2:-BMAL1 
heterodimers induce Rev-erbα transcription while REV-ERBα, in turn, represses the expression 
of these three transcription factors 6-8,11. We here confirm that also in the cerebral cortex 
removing the repression provided by REV-ERBα increases the expression of Bmal1, Npas2, and 
Clock. Consistent with this up-regulation we found the CLOCK/NPAS2:-BMAL1 targets Dbp and 
Per2 to be upregulated as well. PER2, in turn, not only provides negative feedback to 
CLOCK/NPAS2-:BMAL1 induced transcription but, in addition, coordinates the action of 
various nuclear receptors, including REV-ERBα and NURR1, via protein-protein interactions 55. 
Thus REV-ERBα as part of a complex network of interacting transcriptional regulators, seems 
central in changing dopamine turnover. 
The link between dopamine levels and sleep homeostasis is intriguing and could also 
have contributed to the profound sleep homeostatic phenotype we observed in Rev-erbα KO 
mice. This relationship is, however, not straightforward; the mutations in Dat activity referred 
to above led to increased dopamine post-synaptically due to compromised dopamine re-
uptake which was associated with increased homeostatic sleep rebounds 50-52, while in Rev-
erbα KO mice the reduced inhibition of Th expression led to increased dopamine levels pre-
synaptically and, as we show here, was associated with a decreased homeostatic sleep 
rebound. Further illustrating this complexity is the fact that REV-ERBα can directly inhibit the 
expression of the Dopamine D3 receptor 56. The activation of this receptor is thought to be 
inhibitory, reducing novelty seeking behaviors, and to reduce dopamine through post-synaptic 
negative feedback 57. 
 
REV-ERBα and circadian organization of overt behavior 
Although Rev-erbα is important for the circadian molecular circuitry and for setting the phase 
of circadian rhythms in peripheral tissues 12, its lack only modestly affects rhythms in overt 
behaviors. Rev-erbα KO mice do maintain circadian organization of locomotor activity under 
constant conditions albeit with a significantly shorter free-running period 8,12. The earlier 
onset of the main waking period under the entrained conditions of our experiment is 
consistent with a shorter endogenous period although the ca. 24 min shortening of the period 
seems insufficient to account for the >1 h advance of sleep/wake distribution. The inducible 
depletion of both Rev-erbα and its homolog Rev-erbβ does lead to a profound disruption of 
circadian behavior 12 pointing to a functional redundancy between the two at least for this 
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phenotype. Whether also the sleep homeostatic phenotype becomes more pronounced in 
double KO mice remains to be determined. 
 In addition to altered EEG delta power and sleep fragmentation after sleep deprivation, 
we also observed a distinctly different pattern for the recovery of sleep time lost during the 
sleep deprivation to which the advance of the sleep/wake distribution might have 
contributed. In both genotypes, maximal levels of wakefulness are reached within the first 6 
h of the dark period under baseline conditions. After the sleep deprivation, it was during these 
6 h that WT mice adapt their behavior to allow for recovery sleep gaining 35 min of NREM 
sleep. KO mice conspicuously maintain their baseline sleep/wake pattern and did not increase 
NREM sleep time above basal levels. As a consequence of the extra NREM sleep in the 
recovery dark period, EEG delta power in WT mice, exceptionally, reached lower levels than 
KO mice. The inflexibility of Rev-erbα KO mice to mount the appropriate behavioral sleep 
response is reminiscent to that observed in mice lacking the clock gene Npas2 58. Also Npas2 
KO mice have intact circadian behavior but a poor homeostatic response to food or sleep 
deprivation 59. 
 
Sleep deprivation, mood, metabolism, and clock genes 
Strong, bidirectional links exist between sleep and mood disorders, perhaps best illustrated 
by the amazingly rapid, albeit short lasting, antidepressant effects of sleep deprivation in 
depression (reviewed in 60). These beneficial effects of sleep deprivation combined with the 
observation made in some, but not all studies, that EEG delta power is reduced in major 
depressive disorder (reviewed in 61), led to the hypothesis that sleep need accumulates at a 
slower rate during wakefulness and is causally involved in the dysregulation of mood 62. 
Abnormal dynamics in waking theta activity over the course of a sleep deprivation further 
suggest abnormal sleep homeostasis in depressed patients 63. Both the altered theta activity 
in wakefulness and the altered delta activity in NREM sleep we here describe for the KO mice 
are reminiscent of these EEG changes associated with mood disorders. 
Sleep homeostasis and mood disorders could also be linked at the molecular level. 
Many studies reported on the role of clock genes in mood regulation 64,65 and our own work 
revealed a bidirectional relationship between clock genes and sleep homeostasis 66, further 
illustrated here by the altered homeostatic regulation of sleep in Rev-erbα KO mice and by the 
effects of sleep deprivation on the cortical expression of the clock genes Npas2 and Per2, and 
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the clock-controlled transcription factor Dbp. We previously showed that like Dbp, Rev-erbα 
was decreased by sleep deprivation 29. We also quantified two transcripts known to be reliably 
upregulated sleep deprivation; i.e., Homer1a and Sgk1. Although the expression of both was 
indeed increased in the current study, their increase did not differ between genotypes 
pointing to a dissociation between EEG and molecular markers of sleep need. 
Among the clock genes, REV-ERBα seems to play a central role in the regulation of 
mood as evidenced by; e.g., a mania-like behavior in KO mice 40,47,67 and, perhaps, the altered 
sleep homeostasis in the current study. The involvement of REV-ERBα in mood might, in part, 
relate to its role in dopaminergic signaling discussed above. Other likely candidate pathways 
concern REV-ERBα’s role in adult hippocampal neurogenesis 40, which has also been linked to 
mood disorders 68, and its well-established role in metabolism and circadian rhythms 65. One 
important mediator of the increased adult hippocampal neurogenesis is FABP7 40,69, a direct 
target of REV-ERBα 40. Because of the large, 7.5-fold over-expression of Fabp7 in the brain that 
we observed (see Figure 6 and 40), FABP7 might also be involved in mediating other 
phenotypes observed in Rev-erbα KO mice such as anxiety and memory deficits 69-71. 
Concerning the sleep homeostatic phenotype, overexpression of the mouse Fabp7 or its fly 
homologue Fabp-B in the fruit fly Drosophila melanogaster resulted in decreased sleep 
duration and consolidation 70, the Drosophila correlates of reduced homeostatic sleep need 
51,72. Whether FABP7 plays a role in the homeostatic regulation of sleep in mammals has yet 
to be determined. 
Several groups have investigated the role of the core clock genes in sleep homeostasis 
by studying the effects of sleep deprivation on EEG delta power in mice carrying targeted 
disruptions of single or a combination of clock genes 3,4. The first core clock genes for which 
altered sleep–wake dependent dynamics of EEG delta power was demonstrated were the 
Cryptochromes 73. Cry1,2 double KO mice displayed a more rapid build-up of homeostatic sleep 
need during wakefulness resulting in overall higher levels of EEG delta power during baseline, 
explaining the smaller relative increase in EEG delta power after sleep deprivation. In contrast, 
as in our Rev-erbα KO mice, evidence for a slower build rate was obtained in Bmal1 and Npas2 
knock-out mice 58,74, while in Clock-mutant mice no differences were reported 75. Sleep 
homeostasis was also assessed in Per1 and Per2 single and double mutant KO mice but with 
inconsistent outcomes 76,77. These disparate results do not support a simple, unifying 
mechanism through which the clock gene circuitry, as a whole, alters the dynamics of the sleep 
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homeostat but rather suggest that factors such as tissue/cell type-specificity and yet to be 
identified modifiers associated with differences in genetic background play important roles as 
has been demonstrated for circadian-related phenotypes 5. 
 
Conclusion 
REV-ERBα’s role in the control of sleep homeostasis is of particular interest because both the 
molecule and the process are tightly linked to metabolism as well as circadian rhythms (for 
reviews see 3,14,78,79). REV-ERBα’s activity as a transcriptional repressor is modulated by cellular 
redox state through altered binding of its endogenous ligand, heme 80,81. In the context of our 
sleep homeostatic phenotype, Rev-erbα could thus act as a sensor of the metabolic imbalance 
imposed at the neuronal level by periods of extended wakefulness in keeping with our 
proposal that clock genes not only set time-of-day, but in the cerebral cortex, can also be used 
to keep track of and respond to time-spent-awake 3,79. A recent study demonstrated that 
synthetic agonists targeting both REV-ERB proteins leads to a strong, immediate reduction in 
sleep time when administrated at ZT6 82, implying that pharmacologically targeting of REV-
ERBα could be useful in the treatment sleep disorders. 
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Figure Legends 
 
Figure 1. Rev-erbα knockout mice have an earlier increase in wakefulness relative to dark 
onset. A) Mean (± 1 SEM) hourly values of Wakefulness, NREM sleep, and REM sleep over 48h 
baseline. Genotype significantly affected the time course for all three states while the two 
baseline days did not differ [3-way rANOVA, factors genotype (‘G’: KO, WT), day (‘D’: 1, 2), and 
hour (‘H’: 1 - 24); Wakefulness: ‘G’ p = 0.94, ‘D’ p = 0.19, ‘H’ p < 0.001, ‘GxD’ p = 0.33, ‘GxH’ p 
< 0.001, ‘DxH’ p = 0.56; NREMS: ‘G’ p = 0.35, ‘D’ p = 0.12, ‘H’ p < 0.001, ‘GxD’ p = 0.19, ‘GxH’ p 
< 0.001, ‘DxH’ p = 0.46; REMS: ‘G’ p = 0.22, ‘D’ p = 0.13, ‘H’ p < 0.001, ‘GxD’ p = 0.18, ‘GxH’ p < 
0.001, ‘DxH’ p = 0.87]. B) Upper curve: Mean (± 1 SEM) accumulation of time spent awake 
calculated at 1h increments. The two baseline days were averaged. Lower curve: Mean 
differences (KO-WT; ± 1 SED) in accumulated values represented in the upper curve. C) 
Amplitudes of the difference in time spent awake between the two 12h periods. The start time 
of the 12h periods was shifted at 1min increments with 0 shift corresponding to the actual 
dark onset. For each 1min shift the amplitude was calculated. Circles with bi-directional error 
bars indicated the mean (± 1 SEM) of the individual amplitude with 0 shift (symbols labeled 
‘1’; same values as in Table S1) or at the shift yielding maximal amplitude (symbols labeled 
‘2’). All panels, knockout (KO, n=13) and wild type (WT, n=8) mice are indicated with black 
lines and symbols and grey line and open symbols, respectively. Grey areas represent 12h dark 
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periods. Red squares in A) and B) indicate hours with significant genotype differences (post-
hoc t-tests, p < 0.05).  
 
Figure 2. Rev-erbα knockout mice recover less sleep between ZT12 and ZT18 in recovery 
from sleep deprivation compared to their wild type littermates. Recovery-baseline 
differences in NREM sleep and REM sleep time spent in three 6h intervals (i.e., during the light 
from ZT6-12, during the dark from ZT12-18 and ZT18-24). Indicated are the mean (± 1 SEM) 
differences for KO (black bars, n = 13) and WT (white bars, n = 8) mice. Red stars indicate 
significant genotype differences (t-tests, p < 0.05); blue stars significant recovery-baseline 
differences (paired t-tests, p < 0.05). 
 
Figure 3. EEG delta power after sleep onset in baseline and after sleep deprivation is lower 
in the absence of Rev-erbα. A) Mean (± 1 SEM) EEG delta power (upper curves) and NREM 
sleep amount (lower curves) during 48h baseline, 6h sleep deprivation (SD; grey shaded area), 
and 18h recovery. The time course of the changes in EEG delta power during baseline differed 
significantly between KO and WT (3-way rANOVA, factors genotype (‘G’ p < 0.001) and hour 
(‘H’ p < 0.001), ‘GxH’ p < 0.001; analyses of average of 2 baselines). Also in recovery the time 
course of both EEG delta power (2-way rANOVA, ‘G’ p = 0.0012, ‘H’ p<0.001, ‘GxH’ p < 0.001) 
and of the hourly NREM sleep values (2-way rANOVA, ‘G’ p = 0.69, ‘H’ p < 0.001, ‘GxH’ p < 
0.001) were affected by genotype. Intervals in which EEG delta power and NREM sleep in KO 
mice significantly differed from WT are indicated by red squares (post-hoc t-tests, p < 0.05). 
For baseline NREM sleep statistics see Figure 1A. B) Mean (± 1 SEM) level of EEG delta power 
in the first 20 min of NREM sleep after light onset in baseline (average of two days) and after 
the SD. Both KO and WT have a significant increase in EEG delta power after sleep onset in 
baseline and after sleep deprivation compared to their lowest baseline levels (=100%; t-tests, 
p < 0.05) but the levels reached in KO mice were lower in both conditions (red stars; t-tests, p 
< 0.05). C) Recovery-baseline differences (± 1 SEM) in the number of brief awakenings (i.e., 
waking bouts lasting 16 sec or less) interrupting sleep during the first 3 h of the light period in 
baseline (Baseline) and during the 3 first hours at sleep onset after sleep deprivation 
(recovery), contrasted to the number obtained during the last 4 h of the baseline light period 
(= 0 level). The decrease in number of brief awakenings was smaller in KO mice (2-way 
rANOVA, factors genotype (p = 0.01) and day (p < 0.001), interaction p = 0.44). Red stars mark 
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significant genotype differences (post-hoc t-tests; p < 0.05). Note that in recovery, genotype 
difference reached p = 0.06. Also note that while brief awakenings after recovery sleep onset 
was significantly lower than in the last 4 h of the baseline light periods for both genotypes 
(post-hoc t-tests; p < 0.001), after baseline sleep onset, they were reduced in WT mice only 
(post-hoc t-tests, p < 0.001 and p = 0.98 for WT and KO, respectively). 
 
Figure 4. Genotype differences in NREM sleep EEG spectra are specific to the delta 
frequencies activity and appear only when sleep need is high. A) Mean EEG spectral profiles 
in NREM sleep at times when sleep need is assumed to be high; i.e., in the first 3 h after sleep 
onset in baseline [left panel; lines labeled 3 and 4 for WT (grey) and KO (black), resp.] and after 
sleep deprivation [right panel, recovery, lines labeled ‘1’ and ‘2’ for WT (grey) and KO (blue), 
resp.]. For comparison, spectral profiles of NREM sleep in the last 4 h of baseline, which served 
as reference for the analysis of EEG delta power (see Figure 3), when sleep need is lowest, are 
depicted [left panel, dashed lines, labeled ‘5’ and ‘6’ for KO (back) and WT (grey), resp.]. B) 
Genotype differences for the spectral profiles in panels A. Mean spectral KO/WT ratios for 
recovery (blue line labeled ‘2/1’) and baseline (black line; ‘4/3’) were remarkably similar and 
significant differences concerned higher delta frequencies only for both conditions (2.50 - 4.75 
Hz; post-hoc t-tests, p < 0.05, horizontal lines at the bottom), while no significant genotype 
differences were observed when sleep need is low (dashed black line labeled ‘5/6’). C) The 
effect of sleep deprivation on NREM sleep spectra in panel A. Analysis of spectral recovery-to-
baseline (Rec/Bsl) ratios in KO (blue line labeled ‘2/5’) and WT (grey; ‘1/6’) mice demonstrated 
that sleep loss increased EEG power density in frequencies < 21 Hz, while suppressing EEG 
activity in the low gamma range (> 32 Hz) in both genotypes (blue and grey lines at bottom). 
Although shape and the affected frequency ranges were highly similar, both the increases and 
the decreases in EEG power density were smaller in KO mice. Significant genotype differences 
were, however, highly frequency specific and limited to the delta frequency range (1.0 - 3.75 
Hz) and in one frequency bin within the low gamma band (42.5 Hz).  
 
Figure 5. Mean EEG spectral profiles in wakefulness preceding the times at which NREMS 
EEG delta power differed between genotypes. A) Mean spectral profiles in the 3 h before 
sleep onset in baseline (ZT21 - 24; left panel) and the last 3 h of the sleep deprivation (ZT3 - 6; 
right panel; KO black lines, WT grey lines). EEG power density was expressed as a percentage 
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of individual total EEG power (see Methods and FigureS1C). B) Effects of prolonged 
wakefulness on the spectral composition of the waking EEG was assessed by comparing the 
EEG spectra in panels A to the waking spectra obtained in the last 4 h of baseline (ZT8 - 12) 
when sleep need is lowest (see Figure S5 for a genotype comparison of the spectral EEG 
profiles at this time). Mean profiles of spectral ratios (last 3 h / baseline ZT8-12 reference) 
reached in last 3 h of the baseline dark periods (left panel) and the last 3 h of the sleep 
deprivation (right panel) were similar and significant differences concerned a decrease in EEG 
power in high delta frequencies (3 - 6 Hz) and increases in the theta (6.5 - 11 Hz) and gamma 
(40 - 90 Hz) frequency ranges (horizontal lines at bottom of panel; WT grey, KO black; post-
hoc paired t-tests, p < 0.05). These differences were, however, larger in sleep deprivation than 
in baseline (analyses not shown) and larger in WT than KO mice (red horizontal line at bottom 
of panel, post-hoc t-tests p < 0.05). C) The increase in EEG theta power in wakefulness as 
quantified in panel B, predicted the level of EEG delta power reached in NREM sleep after 
sleep onset as quantified in Figure 2B. The changes in theta power were averaged over the 
2Hz frequency range for which significant genotype differences were observed (8.5 - 10.5 Hz). 
For calculation of EEG delta power values see Fig. 2B. Lines represent the linear correlation 
through all KO (black line: delta = 38 ± 9 x theta + 125 ± 8; R2=0.45, p = 0.0002, n = 26) and WT 
(grey line: delta = 50 ± 15 x theta + 133 ± 18; R2 = 0.45, p = 0.0047, n = 16) data points (i.e., Bsl 
+ Rec). Slope and offset did not differ between genotypes. Black symbols: KO (n = 13); grey 
symbols WT (n = 8); circles baseline (Bsl); triangles recovery (Rec). 
 
Figure 6. Cortical expression of several genes is affected by the lack of Rev-erbα and sleep 
deprivation. Mean (1 SEM) levels of mRNA expression in the cortex of WT (n=10) and KO (n=9) 
mice, submitted to either a 6h sleep deprivation from ZT0-6 (SD, black bars) or allowed to 
sleep ad lib (control, white bars). Normalized expression levels (see Methods) are expressed 
relative to the WT control group (set to 1.0). Red stars indicate a significant effect of the sleep 
deprivation within genotypes (p < 0.05; post-hoc t-tests), while blue stars indicate genotype 
differences [2-way ANOVA, factors genotype (‘G’) and sleep condition (‘SD’); Homer1a: ‘G’ p 
= 0.99, ‘SD’ p < 0.001; ‘GxSD’ p = 0.19; Sgk1: ‘G’ p = 0.77, ‘SD’ p < 0.001, ‘GxSD’ p = 0.68; Fabp7: 
‘G’ p < 0.001; ‘SD’ p = 0.98, ‘GxSD’ p = 0.91; Bmal1: ‘G’ p < 0.001, ‘SD’ p = 0.42, ‘GxSD’ p = 0.36; 
Npas2: ‘G’ p = 0.004, ‘SD’ p = 0.003, ‘GxSD’ p = 0.13; Clock: ‘G’ p = 0.02, ‘SD’ p = 0.18, ‘GxSD’ p 
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= 0.73; Dbp: ‘G’ < 0.001, ‘SD’ p = 0.02, ‘GxSD’ p = 0.48; Per2: ‘G’ p = 0.06; ‘SD’ p = 0.003; ‘GxSD’ 
p = 0.84]. 
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Table S1. Time spent asleep and awake in baseline.  
 
 
 
 
 
Upper part: Mean (SEM) time spent in wakefulness, NREM sleep, and REM sleep over 12- and 
24h intervals (KO n=13, WT n=8). Lack of Rev-erbα caused animals to be significantly more 
awake in the light period (t-tests), an effect that was reversed in the dark, resulting in very 
similar 24h values (also see Figure 1). Lower part: Diurnal amplitude of sleep-wake states, 
quantified as the dark-light difference, was significantly smaller in KO mice. All values in 
minutes and based on two baseline days. 
 
  
 12h light 12h dark 24h 
KO WT P KO WT p KO WT p 
Wake 280 (6) 249 (7) 0.003 452 (11) 484 (11) 0.07 732 (13) 733 (15) 0.82 
NREM 372 (7) 390 (6) 0.09 233 (11) 203 (9) 0.06 606 (13) 593 (11) 0.97 
REM 67 (3) 75 (3) 0.11 33 (2) 30 (2) 0.23 101 (3) 105 (4) 0.87 
 12h dark- 12h light 
KO WT P 
Wake 172 (12) 235 (10) 0.002 
NREM -139 (12) -187 (12) 0.02 
REM -34 (3) -45 (3) 0.04 
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Table S2. Sequences of primers and probes used for TaqMan qPCR analysis of selected genes and 
references genes. 
Gene  Direction  Sequence 5' to 3' Accession # 
Symbol       
Homer1a fwd GCATTGCCATTTCCACATAGG NM_011982 
  rev ATGAACTTCCATATTTATCCACCTTACTT   
  probe ACACATTCAATTCAGCAATCATGA   
Bmal1 fwd CAAGAAAGTATGGACACAGACAAA  NM_007489 
  rev GCATTCTTGATCCTTCCTTGGT   
  probe TGACCCTCATGGAAGGTTAGAATATGCAGAAC   
Npas2 fwd GGTCATCGGATTCTTGCAGAA NM_008719 
  rev TCCAGTCCTGCTGGATGTCA   
  probe CACAATGAAGTCTCAGCACAAACAGAAATC   
Per2 fwd ATGCTCGCCATCCACAAGA NM_011066 
  rev GCGGAATCGAATGGGAGAAT   
  probe ATCCTACAGGCCGGTGGACAGCC   
Dbp fwd CGTGGAGGTGCTTAATGACCTTT NM_016974 
  rev CATGGCCTGGAATGCTTGA   
  probe AACCTGATCCCGCTGATCTCGCC   
Sgk1 fwd ACGGTGGACTGGTGGTGTCT NM_011361 
  rev GCCGTGTTCCGGCTATAAAA   
  probe TATGAGATGCTCTACGGCCTGCCCC   
GAPDH fwd CATGGCCTTCCGTGTTCCTA NM_008084 
  rev CCTGCTTCACAACTTTCTTGA   
  probe CCGCCTGGAGAAACCTGCCAAGTATG   
Tbp fwd TTGACCTAAAGACCATTGCACTTC NM_013684 
  rev TTCTCATGATGACTGCAGCAAA   
  probe TGCAAGAAATGCTGAATATAATCCCAAGCG   
Rps9 fwd GACCAGGAGCTAAAGTTGATTGGA NM_029767 
  rev TCTTGGCCAGGGTAAACTTGA   
  probe AAACCTCACGTTTGTTCCGGAGTCCATACT   
Eef1a fwd CCTGGCAAGCCCATGTGT NM_010106 
  rev TCATGTCACGAACAGCAAAGC   
  probe TGAGAGCTTCTCTGACTACCCTCCACTTGGT   
Fabp7 fwd TTTCTGCGCAACCTGGAAG NM_021272 
  rev CACGTTTCCCACTTGCCTAG  
  probe AAGCTCTGGGCGTGGGCTTTGC  
Clock fwd Mm00455950_m1 NM_007715.5 
  rev TaqMan Expression Assay, Life Technologies   
  probe    
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Figure S1. Number of brief awakenings during the 4 last hours of light period (ZT8-12). The 
mean (+ 1 SEM; expressed per hour of sleep) number of brief awakenings did not differ 
between genotypes (t-test, p = 0.44). The number of brief awakenings obtained at this time 
of day is used as a reference for the analysis presented in Figure 3C. 
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Figure S2: Spectral composition of EEG activity during wakefulness, NREM sleep, and REM 
sleep in baseline. A) Mean spectral profiles calculated over the two baseline days during 
wakefulness (upper, left), NREM sleep (upper, middle), and REM sleep (upper, right panel) 
together with their KO/WT spectral ratios (three lower panels). When averaged over the entire 
24h day the NREM sleep EEG spectra do not differ between genotypes. In waking and REM 
sleep EEG power density between 1.5 - 5.5 Hz, 11 - 20 Hz, and, for wakefulness, between 33 - 
42 Hz, was higher in KO mice (red horizontal lines at bottom; post-hoc t-test, P<0.05). The 
significant decrease in KO mice in the theta frequency range in wakefulness was not due to a 
lower theta activity but to a slowing of the dominant theta frequency. B) Theta peak 
frequency, but not theta peak power, was reduced in KO mice both in baseline (bsl, left panel; 
-0.9 Hz) and sleep deprivation (SD, right panel; -0.5 Hz; red stars; t-test P<0.05; mean ± bi-
directional SEM). Note that vertical scales differ between the two panels. Theta peak 
frequency during REM sleep was not affected by genotype (analysis not shown). C) Total EEG 
power calculated in baseline, which served as an individual reference to calculate relative EEG 
spectra, did not differ between genotypes. This reference was used for the analyses shown 
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Figures S2A, S3, 4, and 5. The genotype differences in the relative EEG spectra depicted in 
panel A were similarly observed for the absolute EEG spectra although frequency ranges that 
significantly differed were smaller due to a larger inter-individual variation (data not shown). 
 
 
 
 
 
 
 
Figure S3. Spectral profiles of the waking EEG obtained in the last 4h of the baseline light 
periods. Upper panel: Mean spectral profiles of the baseline waking EEG between ZT8-12 used 
as reference for the analysis in Figure 4B (KO black, WT grey line). EEG power density was 
expressed as a percentage of individual total EEG power (see Methods and FigureS1C). Lower 
panel: Genotype differences (KO/WT) for the spectra in the upper panel were limited to the 
high delta frequencies (2.25 - 4.5 Hz; red squares; post-hoc t-tests, p < 0.05).  
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